27.09.2011
- Actelion announced that Jean-Pierre Garnier has become Chairman of the Board of Directors of the Swiss biopharmaceutical company. The Board of Directors elected him at their...
30.06.2011
- The strong Swiss franc is putting Swiss exporters at a strong disadvantage to their foreign competitors, industry body Swissmem said, likening the firms to a sprinter who has to...
14.06.2011
- Biotech deals in the $1 billion to $5 billion range are likely to be a sweet spot for drug companies looking to bolster their pipelines through M&A in an increasingly tough...
07.06.2011
- Actelion, Europe's largest biotech company which has been under pressure from activist investor Elliott Advisors, is changing its management structure, including appointing a chief...
04.05.2011
- Europe's largest biotech Actelion was dealt a blow when a jury in a Californian court said Japanese drugmaker Asahi Kasei should be awarded up to $547 million in a licensing...
02.05.2011
- Swiss biotech group Actelion is now facing a tougher battle at its annual general meeting this week after a jury decided Asahi Kasei Pharma Corporation should be awarded up to $547...
02.05.2011
- Swiss biotech group Actelion may appeal against a jury's decision in a Californian court to award Asahi Kasei Pharma Corporation up to $547 million in a dispute with Actelion unit...
27.04.2011
- U.S. hedge fund group Elliott Associates has raised its stake in Danish company Danisco to 4.9% to put pressure on DuPont to raise its bid for the food ingredients and enzymes...
